ATE284217T1 - Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen - Google Patents

Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen

Info

Publication number
ATE284217T1
ATE284217T1 AT97922261T AT97922261T ATE284217T1 AT E284217 T1 ATE284217 T1 AT E284217T1 AT 97922261 T AT97922261 T AT 97922261T AT 97922261 T AT97922261 T AT 97922261T AT E284217 T1 ATE284217 T1 AT E284217T1
Authority
AT
Austria
Prior art keywords
pct
treatment
skin diseases
inflammatory skin
sqdg
Prior art date
Application number
AT97922261T
Other languages
English (en)
Inventor
Mervi Vasaenge
Wenche Rolfsen
Lars Bohlin
Original Assignee
Scotia Lipidteknik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20402430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE284217(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scotia Lipidteknik Ab filed Critical Scotia Lipidteknik Ab
Application granted granted Critical
Publication of ATE284217T1 publication Critical patent/ATE284217T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
AT97922261T 1996-05-02 1997-04-30 Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen ATE284217T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601677A SE9601677D0 (sv) 1996-05-02 1996-05-02 New use
PCT/SE1997/000735 WO1997040838A1 (en) 1996-05-02 1997-04-30 New use

Publications (1)

Publication Number Publication Date
ATE284217T1 true ATE284217T1 (de) 2004-12-15

Family

ID=20402430

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97922261T ATE284217T1 (de) 1996-05-02 1997-04-30 Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen

Country Status (10)

Country Link
US (1) US6124266A (de)
EP (1) EP0952836B1 (de)
JP (1) JP2000509386A (de)
AT (1) ATE284217T1 (de)
AU (1) AU707677B2 (de)
CA (1) CA2253440A1 (de)
DE (1) DE69731898T2 (de)
NZ (1) NZ332811A (de)
SE (1) SE9601677D0 (de)
WO (1) WO1997040838A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044642A1 (en) * 1998-03-05 1999-09-10 Phares Pharmaceutical Research Nv Pharmaceutical compositions and their use
JP3851461B2 (ja) 1998-09-04 2006-11-29 東洋水産株式会社 ピラノシドおよびその製造方法
DE60003794T2 (de) 1999-02-26 2004-06-17 Toyo Suisan Kaisha, Ltd. Sulforhamnosylacylglycerin-derivate und ihre verwendung als medikamente
JP3740018B2 (ja) 1999-02-26 2006-01-25 東洋水産株式会社 新規なスルホフコシルアシルグリセロール誘導体およびその医薬としての用途
CA2365359C (en) 1999-02-26 2007-09-18 Toyo Suisan Kaisha, Ltd. Medicaments containing a sulfopyranosylglycerol derivative
US6518410B2 (en) 1999-02-26 2003-02-11 Toyo Suisan Kaisha, Ltd. Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments
CA2293852A1 (fr) 1999-12-30 2001-06-30 Purecell Technologies Inc. Procede de preparation d'extraits de plantes actifs et utiles a la capture de radicaux libres; les extraits, et compositions et dispositifs les comprenant
US20040091477A1 (en) * 2001-05-08 2004-05-13 David Haines Immunosuppresive compositions
ATE426406T1 (de) 2001-07-09 2009-04-15 Toyo Suisan Kaisha Neue immunsuppressiva
FR2840318B1 (fr) * 2002-05-29 2004-12-03 Quoc Kiet Pham Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 Ｌ−セレクチン結合阻害剤
CN101563082A (zh) * 2006-09-05 2009-10-21 窦德献 治疗免疫介导性皮肤病的组合物和方法
MX2009004962A (es) * 2006-11-07 2009-05-21 Alcon Res Ltd Metodo para tratar asma, rinitis alergia y trastornos de la piel.
EP2389816A1 (de) 2010-05-25 2011-11-30 Nestec S.A. Synergistische Antioxidanszusammensetzung
ITMI20130949A1 (it) * 2013-06-10 2014-12-11 Consiglio Nazionale Ricerche Uso e preparazione di glicolipidi come adiuvanti in vaccini
CN105131055B (zh) * 2015-08-18 2018-02-13 四川大学 一种制备硫代异鼠李糖甘油二酯的方法
CN106974925B (zh) * 2017-05-31 2021-02-05 中国海洋大学 一种硫代异鼠李糖基二酰甘油酯的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2872694B2 (ja) * 1989-07-19 1999-03-17 エーザイ株式会社 血管内血液凝固症候群の治療剤
JP2872695B2 (ja) * 1989-07-19 1999-03-17 エーザイ株式会社 腎炎の治療剤
AU6821294A (en) * 1993-04-30 1994-11-21 Rodner R. Winget Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
US5614197A (en) * 1995-02-13 1997-03-25 Industrial Farmaceutica Cantabria, S.A. Polypodium extract as photoprotectant

Also Published As

Publication number Publication date
DE69731898T2 (de) 2005-12-01
US6124266A (en) 2000-09-26
DE69731898D1 (de) 2005-01-13
JP2000509386A (ja) 2000-07-25
EP0952836B1 (de) 2004-12-08
SE9601677D0 (sv) 1996-05-02
EP0952836A1 (de) 1999-11-03
AU707677B2 (en) 1999-07-15
WO1997040838A1 (en) 1997-11-06
AU2797797A (en) 1997-11-19
CA2253440A1 (en) 1997-11-06
NZ332811A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
ATE284217T1 (de) Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
ATE224374T1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
FR2562539B1 (fr) Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands
ATE264676T1 (de) Verwendung von dha in der behandlung von dyslexie
ATE253586T1 (de) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivat
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
PT1119362E (pt) Metodos de utilizacao de compostos tetraciclina para aumentar a producao de interleucina-10
AR009357A1 (es) Compuesto de amidas de acido fosfinico y sus usos para preparar una composicion farmaceutica y en un metodo para prevenir o tratar unaenfermedad asociada a la actividad de metaloproteasa
DE69217945D1 (de) Azanorbornanderivate
DE60010675D1 (de) Caspase inhibitoren und deren verwendung
UY26256A1 (es) Amidas de ácidos carboxílicos, medicamentos que contienen estos compuestos, su utilización y su preparación
ATE214608T1 (de) Verwendung einer kombination bestehend aus einem aminderivat oder aminverwandten derivat der benzoesäure und einem amino-polysaccharide zur herstellung eines medikaments fuer die behandlung von entzündlichen erkrankungen
DE69526353D1 (de) Immunologische aktivität der rhamnolipide
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
ATE310511T1 (de) Verwendung von konjugierten linoleinsäure zur behandlung von type ii diabetes
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
DE59305464D1 (de) Verwendung von kokosvorlauffettsäure zur insektenabwehr
DE69806622D1 (de) Kosmetische formulierungen zur verhütung und behandlung von haarausfall
ATE311871T1 (de) Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
DE69510338D1 (de) Azirdin-derivate, deren herstellung und verwendung
FR2380285A1 (fr) Nouveaux derives insatures d'acides 7-acylamido-3-cephem-4-carboxyliques, utiles notamment comme agents antibacteriens, et leur procede de preparation
DE60016181D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
KR950031085A (ko) 표피증식 질환 치료용 의약 조성물
ATE248156T1 (de) Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties